Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli

scientific article published on December 15, 1977

Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0014-2999(77)90236-9
P953full work available at URLhttps://api.elsevier.com/content/article/PII:0014299977902369?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:0014299977902369?httpAccept=text/xml
P698PubMed publication ID201475

P2093author name stringB. V. Clineschmidt
J. C. McGuffin
P2860cites workNeurotensin: central nervous system effects of a hypothalamic peptideQ41279452
Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranesQ43565652
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
P304page(s)395-396
P577publication date1977-12-01
1977-12-15
P1433published inEuropean Journal of PharmacologyQ1376712
P1476titleNeurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli
P478volume46

Reverse relations

cites work (P2860)
Q48403335Age-related changes in neurotensin content and receptors in various rat brain areas
Q34039450Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine
Q72718895Antinociceptive action of intrathecal neurotensin in mice
Q49078139Antinocisponsive effects of neurotensin and neurotensin-related peptides
Q45774676Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat.
Q48693739Behavioral effects of hypothalamic hypophysiotropic hormones, neurotensin, substance P and other neuropeptides
Q52290739Behavioral effects of neurotensin.
Q90720089Beneficial Effects of Neurotensin in Murine Model of Hapten-Induced Asthma
Q40085145Biological Perspectives in Chronic Pain, Depression, and Organic Mental Disorders
Q72852499Bombesin: Receptor distribution in brain and effects on nociception and locomotor activity
Q39453617Characterization of biphasic modulation of spinal nociceptive transmission by neurotensin in the rat rostral ventromedial medulla
Q31878460Cold water swim stress increases the expression of neurotensin mRNA in the lateral hypothalamus and medial preoptic regions of the rat brain.
Q36894729Comparative antipsychotic profiles of neurotensin and a related systemically active peptide agonist
Q39253697Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand
Q70955205Differential neurobehavioral effects of neurotensin and structural analogues
Q44651935Differential sensitivity to neurotensin-induced hypothermia, but not analgesia, in Fischer and Lewis rats
Q48757743Distribution and origins of neurotensin-containing fibers in the nucleus ventromedialis hypothalami of the rat: an experimental immunohistochemical study
Q70755638Distribution of NT-IR perikarya in the brain of the guinea pig with special reference to cardiovascular centers in the medulla oblongata
Q40134265Distribution of neurotensin and its receptor in the central nervous system
Q72150051Distribution of neurotensin-containing neurons in the central nervous system of the dog
Q30456105Diverse roles of neurotensin agonists in the central nervous system
Q49070358Effect of centrally administered neurotensin on multiple feeding paradigms
Q49129426Effect of dorsal rhizotomy on the autoradiographic distribution of opiate and neurotensin receptors and neurotensin-like immunoreactivity within the rat spinal cord
Q72550135Electrophysiological studies on the neuroactive properties of neurotensin
Q73525799Highly potent neurotensin analog that causes hypothermia and antinociception
Q34012771Identification and functional characterization of a stable, centrally active derivative of the neurotensin (8-13) fragment as a potential first-in-class analgesic
Q34435669Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound
Q34164864Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2
Q34977637Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2
Q88061348In Search of the Optimal Macrocyclization Site for Neurotensin
Q48148694In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier
Q48750625Interactions between neurotensin and dopamine in the brain: An overview
Q72634344Neuropeptides and Monoaminergic Neurotransmitters: Their Relation to Pain
Q42246826Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation
Q35152140Neurotensin agonists: possible drugs for treatment of psychostimulant abuse
Q48138045Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover
Q34441055Neurotensin and the serotonergic system
Q28580090Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey
Q40273912Neurotensin receptors: Autoradiographic localization in rat CNS
Q41062208Neurotensin-containing cell bodies, fibers and nerve terminals in the brain stem of the rat: Immunohistochemical mapping
Q41445511Neurotensin: Antinocisponsive action in rodents
Q49095946Neurotensin: regional distribution, characterization, and inactivation
Q48648344Ontogeny of brain neurotensin in the rat: a radioimmunoassay study
Q70259041Ontogeny of neurotensin-containing neuron system of the rat: Immunohistochemical analysis—II. Lower brain stem
Q48932375Ontogeny of the neurotensin-containing neuron system of the rat: immunohistochemical analysis. I. Forebrain and diencephalon
Q48620352Pain Threshold Changes in Rats Following Central Injection of Beta-Endorphin, Met-Enkephalin, Vasopressin or Oxytocin Antisera
Q72742950Peptides and Nociception
Q35273495Physiological mechanisms of the analgesic effect of neurotensin
Q28271138Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors
Q33864641Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligand
Q27630616Structure of neurolysin reveals a deep channel that limits substrate access
Q41739863Structure-antinociceptive activity studies with neurotensin
Q34128818Systemically and topically active antinociceptive neurotensin compounds
Q35564800The amide linker in nonpeptide neurotensin receptor ligands plays a key role in calcium signaling at the neurotensin receptor type 2.
Q72694436The effects of centrally administered antisera to neurotensin and related peptides upon nociception and related behaviors
Q70453163The effects of chronic morphine treatment on neurotensin-induced antinociception
Q39738313The relationship between cardiovascular and pain regulatory systems
Q35175664The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia
Q36544566The role of neurotensin in central nervous system pathophysiology: what is the evidence?
Q63608737Ultrastructural localization of immunoreactive neurotensin in the monkey superficial dorsal horn

Search more.